ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000226263.1	Selumetinib	Breast invasive carcinoma	0.034175139	Resistant
ENSG00000226263.1	Selumetinib	Colon adenocarcinoma	0.008933514	Sensitive